| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2146369 | Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis | 2014 | 8 Pages |
Abstract
This study shows that the ERCC1 C118T variants are not associated with survival in ACC patients treated with oxaliplatin or the in vitro sensitivity and DNA-repair capacity in 118C and 118T transfected cell lines. Therefore, ERCC1 C118T genotyping seems of no value in individualizing oxaliplatin based chemotherapy in ACC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Lieke H. van Huis-Tanja, Dina M. Kweekel, Xiaobo Lu, Kees Franken, Miriam Koopman, Hans Gelderblom, Ninja F. Antonini, Cornelis J.A. Punt, Henk-Jan Guchelaar, Tahar van der Straaten,